SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending as investors discuss the potential impact of today's insider and early investor lockup expiration, which could significantly increase the stock's float and volatility. The community is weighing the possibility of a price dip due to increased selling pressure against the company's strong cash position and growth potential, drawing comparisons to other fintech stocks like $SOFI and $HOOD.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

UPC is trending due to discussions around its low float and substantial cash reserves, leading to speculation about a potential massive upside. Community members are actively discussing price targets and catalysts that could send the stock to double digits, while drawing comparisons to other recent low-float runners. The stock's potential is being weighed against its history of volatility and pump-and-dump schemes.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recently closed $75 million investment aimed at accelerating growth in AI connectivity solutions. The community is speculating about the investor and discussing potential acquisitions, with many expressing bullish sentiment and anticipating significant upward movement. High trading volume and unusual options activity further fuel the excitement around POET's role in the AI sector.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as investors react to a new multi-launch contract, with community members actively discussing potential short squeezes and the stock's recent surge. Bullish sentiment is fueled by the contract news and dark pool activity, while some caution against overvaluation and potential pullbacks. The conversation also includes speculation about upcoming news and Neutron launch.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors speculate on potential partnerships with major auto manufacturers, fueled by recent deals with Corning and Murata. The community is excited about the company's solid-state battery technology and its potential to disrupt the EV market, particularly with discussions around possible collaborations with Tesla or Apple.  Traders are closely watching for further news and OEM announcements, anticipating a significant impact on the stock's value.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies Corp. is trending as investors discuss its potential in quantum-safe cybersecurity, especially following news of Radical Semiconductor co-founders joining the team. Community members highlight the company's unique position in securing crypto payments and its relatively low market cap compared to competitors. Some are speculating on potential partnerships and revenue growth, leading to increased interest and trading volume.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to a massive price surge and high trading volume, reminiscent of recent low-float runners. The community is actively debating whether it's a short squeeze or a pump and dump, with some anticipating further upward movement while others warn of a potential crash. Discussions also involve comparisons to other similar stocks and speculation about potential catalysts or news driving the volatility.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

Shares of ATON are experiencing significant pre-market momentum, with traders actively discussing its low float and potential for continued gains. Community members are highlighting the stock's technical breakout and referencing potential catalysts related to its strategic focus on building a TON token treasury. Some caution against chasing the rally, while others suggest it has significant room to run given its connection to the Telegram ecosystem.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as discussions revolve around its high valuation and potential bubble status, especially given the former CEO's recent share sales. While some community members express bearish sentiments and anticipate a price correction, others remain bullish, citing the company's partnerships and long-term potential in the quantum computing sector. The debate also includes comparisons to other quantum computing stocks and established tech companies.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending due to a $500 million share offering, which has led to a temporary dip as some investors take profits, while others view it as a buying opportunity for the long term. The community is actively discussing the dilution impact, the timing of the offering relative to the company's cash position, and the potential for future growth in the eVTOL sector. Despite a neutral rating from Cantor Fitzgerald, the stock's overall upward trajectory this year keeps investors focused on upcoming certification and commercial launch milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?

Shattuck Labs (STTK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK). Investors who...

STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm STTK INVESTOR ALERT: Bronstein, Gewirtz and...

GXO Logistics, Inc. (<a class="mention" data-mention="$GXO" data-symbol-id="GXO" href="https://stocktwits.com/symbol/GXO" target="_blank">$GXO</a>)<figure class="image"><img style="aspect-ratio:1322/328;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GXO_sentiment_and_message_volume_Oct_10_3420b2072a.png" alt="GXO sentiment and message volume Oct 10.png" width="1322" height="328"><figcaption>GXO sentiment and message volume Oct 10 2024 as of 11:30 am ET</figcaption></figure>Shares of GXO Logistics surged 14% on Thursday after Bloomberg reported that the company is working with financial advisers to explore a potential sale. GXO, a supply-chain services provider that spun off from XPO Inc. in 2021, reportedly began reviewing its options following interest from potential buyers. While no final decision has been made, GXO may still choose to remain independent.On Stocktwits, retail sentiment was ‘extremely bullish’ (97/100).Momentus, Inc. (<a class="mention" data-mention="$MNTS" data-symbol-id="MNTS" href="https://stocktwits.com/symbol/MNTS" target="_blank">$MNTS</a>)<figure class="image"><img style="aspect-ratio:1322/328;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/MNTS_sentiment_and_message_volume_Oct_10_fb513b23c6.png" alt="MNTS sentiment and message volume Oct 10.png" width="1322" height="328"><figcaption>MNTS sentiment and message volume Oct 10 2024 as of 11:30 am ET</figcaption></figure>Momentus Inc. shares skyrocketed 155% in the previous session after the company was selected by NASA to provide launch services for future missions under NASA’s VADR (Venture-Class Acquisition of Dedicated and Rideshare) contract. This agreement gives Momentus a key role in launching satellites like Class D, CubeSats, and other high-risk payloads to various orbits.Retail sentiment on Stocktwits remained ‘extremely bullish’ (95/100) Thursday, despite heavy profit-taking.Shattuck Labs, Inc. (<a class="mention" data-mention="$STTK" data-symbol-id="STTK" href="https://stocktwits.com/symbol/STTK" target="_blank">$STTK</a>)<figure class="image"><img style="aspect-ratio:1322/328;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/STTK_sentiment_and_message_volume_Oct_10_72dde25c07.png" alt="STTK sentiment and message volume Oct 10.png" width="1322" height="328"><figcaption>STTK sentiment and message volume Oct 10 2024 as of 11:30 am ET</figcaption></figure>Shattuck Labs, which specializes in developing immunotherapies, saw its stock rise over 4% on Thursday following insider trading activity. Earlier this week, CEO Taylor Schreiber purchased 36,500 shares at $1.21 each, totaling $44,165. This buy follows another acquisition in June 2024, when Schreiber picked up 14,400 shares.Retail sentiment on Stocktwits was ‘extremely bullish’ (95/100).Read next: <a href="https://stocktwits.com/news-articles/markets/equity/pfe-stock-falls-after-starboard-loses-backing-from-former-exec/cJck6gWREM">Pfizer Stock Falls As Former Execs Pull Back From Starboard’s Activist Campaign: Retail Still Sees Hope</a>

GXO Logistics, Momentus, Shattuck Labs: 3 Stocks Retail Investors Are Most Bullish On Today 

Potential sale talks, NASA contracts, and insider buybacks are sparking strong interest 

Equity

Potential sale talks, NASA contracts, and insider buybacks are sparking strong interest 


Shattuck Labs Inc. (STTK) plunged 43% on Tuesday, marking its steepest one-day decline ever, following the failure of its lead experimental cancer therapy, SL-172154, in an early-stage clinical trial.The stock, the second-biggest loser across U.S. exchanges on Tuesday afternoon, saw retail sentiment nosedive to ‘extremely bearish’ (8/100) territory, with message volume spiking on Stocktwits.<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/STTK_sentiment_and_message_volume_Oct_1_1cc965d42d.png" alt="STTK sentiment and message volume Oct 1.png">Shattuck announced it will discontinue development of SL-172154 after the trial delivered only modest improvements in overall survival rates.The Austin-based biotech firm also revealed plans to cut 40% of its workforce as part of a broader restructuring, shifting its focus to SL-325, an early-stage treatment for inflammatory bowel disease.The company expects restructuring costs to range between $1.5 million and $1.75 million.In another blow, Shattuck terminated a potentially lucrative licensing agreement with Japan’s Ono Pharmaceutical Co., further dampening its prospects.As of June 30, Shattuck reported cash reserves totaling $105.3 million.Tuesday’s brutal drop extends STTK’s year-to-date losses to approximately 73%, with the day’s trading volume exceeding 10 million shares — far above the average daily volume of about 197,000.Shattuck, which went public in October 2020 with high hopes for its cancer treatments, is now scrambling to regroup as investor enthusiasm has evaporated.&nbsp;Read next: <a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-rises-ahead-of-earnings/cJTyXSOR31">Nike Stock Gains As Q1 Earnings Loom: Retail Investors See Rebound Potential Despite Wall Street Concerns</a>

These stocks hit a new 52-week high today

Shattuck Labs Stock Nosedives As Lead Cancer Therapy Fails: Retail Enthusiasm Evaporates

The Austin-based biotech firm also revealed plans to cut 40% of its workforce as part of a broader restructuring

Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline

Shattuck Labs shifts focus to SL-325 after modest survival improvements in a Phase 1 trial for HR-MDS and TP53m AML. The company plans workforce reductions and expects cash reserves to last into...

Shattuck Labs Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Latest Ratings for STTK
 DateFirmActionFromTo Apr 2021BerenbergInitiates Coverage OnBuy Jan 2021Evercore ISI GroupInitiates Coverage OnOutperform Nov 2020Cowen & Co.Initiates Coverage OnOutperform...

Shattuck Labs, Inc. is a biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Shattuck Labs Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$2.45
Prev Close	$2.59
Open	$2.61
Dividend Yield	0.00%
50-Day Moving Average	$1.47
Beta	1.59
Avg. Volume	1.42M
PE Ratio	-2.14

52-Week High	$2.64
52-Week Low	$0.6922
Market Capitalization	$163.56M
EPS (Annual)	-$1.49
Price to Book	2.18
Revenue Per Employee	$130,022.73
Enterprise Value/EBITDA	N/A

STTK Shattuck Labs Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STTK News